"REVOSTATIN CV 10: Dual Heart Protection"

May 14, 2024

REVOSTATIN CV 10 

Rosuvastatin (10mg), Clopidogrel (75mg)

Understanding Rosuvastatin (10mg) in REVOSTATIN CV 10

Rosuvastatin, as part of the REVOSTATIN CV 10 formulation, is a statin medication widely recognized for its efficacy in lowering cholesterol levels. By inhibiting the enzyme HMG-CoA reductase, Rosuvastatin effectively reduces the production of cholesterol in the liver, which is crucial for patients at risk of cardiovascular diseases. Regular use of Rosuvastatin can significantly decrease the risk of heart attacks and strokes by maintaining optimal cholesterol levels.

Clopidogrel (75mg): Enhancing Cardiovascular Protection

Clopidogrel, the other key component of REVOSTATIN CV 10, is an antiplatelet drug that prevents blood clots. It works by irreversibly binding to the P2Y12 receptor on platelets, inhibiting their aggregation and reducing the risk of clot formation. This is particularly beneficial for patients with a history of coronary artery disease, peripheral vascular disease, and cerebrovascular disease, offering them enhanced protection against thrombotic cardiovascular events.

Combined Benefits of Rosuvastatin and Clopidogrel in REVOSTATIN CV 10

The dual action of Rosuvastatin and Clopidogrel in REVOSTATIN CV 10 offers comprehensive cardiovascular protection. This combination not only helps in reducing cholesterol levels but also minimizes the risk of clot-related complications. It is an ideal choice for patients needing both cholesterol management and antiplatelet therapy.

Ideal Candidates for REVOSTATIN CV 10

REVOSTATIN CV 10 is particularly suitable for patients at high risk of cardiovascular events who require aggressive management of their cholesterol levels and clot prevention. It is recommended for patients with existing cardiovascular conditions or those who are at significant risk due to family history or lifestyle factors.

Conclusion

REVOSTATIN CV 10 represents a significant advancement in cardiovascular treatment, combining Rosuvastatin and Clopidogrel's benefits into a single formulation. It provides a convenient and effective solution for managing key risk factors associated with heart disease.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 


 

SHARE WITH